Cerebrospinal Fluid Amyloid-β (Aβ) as an Effect Biomarker for Brain Aβ Lowering Verified by Quantitative Preclinical AnalysesYasong Lu, Martin Pettersson, Kathleen M. Wood et al.|Journal of Pharmacology and Experimental Therapeutics|2012Cited by 36
P4‐315: Evaluating amyloid‐beta processing using novel gamma‐secretase modulators in preclinical animal modelsKathleen M. Wood, Kelly R. Bales, Cathleen Gonzales et al.|Alzheimer s & Dementia|2015Cited by 1